Stock comparison
ELI LILLY & Co is 2.6x more valuable than AbbVie Inc. by market capitalization ($1.142 T vs $440.14 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 2.6x more valuable than AbbVie Inc. by market capitalization ($1.142 T vs $440.14 B).
Market value leader
LLY
ELI LILLY & Co is 2.6x more valuable than AbbVie Inc. by market capitalization ($1.142 T vs $440.14 B).
Revenue leader
LLY
LLY: $65.18B vs ABBV: $61.16B.
Profit leader
LLY
LLY: $20.64B vs ABBV: $4.23B.
Margin leader
LLY
LLY: 31.7% vs ABBV: 6.9% net margin.
| Metric | LLY | ABBV |
|---|---|---|
| Market cap | $1.142 T | $440.14 B |
| US-listed rank | #10 | #25 |
| Revenue (latest FY) | $65.18B | $61.16B |
| Net income (latest FY) | $20.64B | $4.23B |
| Net margin | 31.7% | 6.9% |
| P/E (trailing FY) | 55.3x | 104.2x |
| SEC filings | 995 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 2.6x more valuable than AbbVie Inc. by market capitalization ($1.142 T vs $440.14 B).
In their latest fiscal years, ELI LILLY & Co reported $65.18B in revenue while AbbVie Inc. reported $61.16B.
Full pages: ELI LILLY & Co and AbbVie Inc., or browse the full rankings.